Best Practices: Practical Guidance in Treating Advanced NSCLC with Immunotherapy
Jonathan Wesley Riess, MD, MS Medical Director of Thoracic Oncology Associate Professor, Hematology and Oncology University of California UC Davis Comprehensive Cancer Center Sacramento, CA Introduction Lung cancer is the second-most common type of cancer in the United States, including approximately 235,000 new cases each year, 84% of which are [ Read More ]